19,811 XNAS Volume
XNAS 01 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Matthew J. D'Onofrio | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 2.80 per share. | 21 Mar 2025 | 1,000 | 9,820 (0%) | 0% | 2.8 | 2,797 | Common Stock |
| Mark A. Kowieski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.21 per share. | 20 Mar 2025 | 4,500 | 4,916 (0%) | 0% | 3.2 | 14,463 | Common Stock |
| Matthew J. D'Onofrio | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 3.65 per share. | 28 Feb 2025 | 6,849 | 8,820 (0%) | 0% | 3.7 | 24,999 | Common Stock |
| Cam L. Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 8,750 | 8,750 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 5,833 | 5,833 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 5,833 | 5,833 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 5,833 | 5,833 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Vickie W. Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 5,833 | 5,833 | - | - | Stock Option (Right to Buy) | |
| Mark A. Kowieski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Benjamin Smeal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 5,833 | 5,833 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 64,840 | 64,840 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 17,291 | 17,291 | - | - | Stock Option (Right to Buy) | |
| Mark A. Kowieski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 17,291 | 17,291 | - | - | Stock Option (Right to Buy) | |
| Cam L. Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 17,750 | 17,750 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 14,250 | 14,250 | - | - | Stock Option (Right to Buy) | |
| Vickie W. Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Cam L. Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 17,750 | 17,750 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 14,250 | 14,250 | - | - | Stock Option (Right to Buy) | |
| Vickie W. Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | President & Chief Op. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Cam L. Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 67,500 | 67,500 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 57,750 | 57,750 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 57,750 | 57,750 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | |
| Vickie S. Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 58,000 | 58,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 415,000 | 415,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.94 per share. | 11 Dec 2020 | 23,954 | 339,782 (1%) | 0% | 2.9 | 70,425 | Common Stock |
| David A. Gonyer | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.90 per share. | 11 Dec 2020 | 48,046 | 363,736 (1%) | 0% | 2.9 | 139,333 | Common Stock |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale of securities on an exchange or to another person at price $ 2.95 per share. | 10 Dec 2020 | 5,643 | 324,354 (1%) | 0% | 3.0 | 16,647 | Common Stock |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale of securities on an exchange or to another person at price $ 2.91 per share. | 10 Dec 2020 | 40,357 | 283,997 (1%) | 0% | 2.9 | 117,439 | Common Stock |
| David A. Gonyer | Director, President and CEO | Other type of transaction at price $ 1.05 per share. | 01 Sep 2020 | 20,238 | 339,782 (1%) | 0% | 1.1 | 21,250 | Common Stock |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Other type of transaction at price $ 1.05 per share. | 01 Sep 2020 | 20,238 | 283,997 (1%) | 0% | 1.1 | 21,250 | Common Stock |
| Marilyn R. Carlson | Chief Medical Officer | Other type of transaction at price $ 1.05 per share. | 01 Sep 2020 | 20,238 | 51,876 (0%) | 0% | 1.1 | 21,250 | Common Stock |
| Cam L. Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 67,500 | 67,500 | - | - | Stock Option (Right to Buy) | |
| Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 61,750 | 61,750 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 57,750 | 57,750 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 54,000 | 54,000 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.85 per share. | 28 Feb 2020 | 25,000 | 263,759 (1%) | 0% | 0.9 | 21,250 | Common Stock |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2020 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 225,000 | 0 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 225,000 | 0 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 63,750 | 63,750 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 53,015 | 53,015 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 168,750 | 168,750 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 168,750 | 168,750 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 168,750 | 168,750 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 85,000 | 0 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 70,687 | 0 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 225,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 39,375 | 39,375 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 48,750 | 48,750 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 65,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 70,687 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 52,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 112,500 | 112,500 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 112,500 | 112,500 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 112,500 | 112,500 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 53,015 | 53,015 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 56,250 | 56,250 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 75,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 33,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2019 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 25,312 | 25,312 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 93,750 | 93,750 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 93,750 | 93,750 | - | - | Stock Option (Right to Buy) | |
| Cam L. Garner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Ann D. Rhoads | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 36,500 | 36,500 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2019 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2019 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Other type of transaction at price $ 1.63 per share. | 31 Aug 2018 | 6,901 | 319,544 (1%) | 0% | 1.6 | 11,249 | Common Stock |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Other type of transaction at price $ 1.63 per share. | 31 Aug 2018 | 13,036 | 238,759 (1%) | 0% | 1.6 | 21,249 | Common Stock |
| Marilyn R. Carlson | Chief Medical Officer | Other type of transaction at price $ 1.63 per share. | 31 Aug 2018 | 3,101 | 31,638 (0%) | 0% | 1.6 | 5,055 | Common Stock |
| Cam L. Garner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2018 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Scott L. Glenn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2018 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Ann D. Rhoads | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2018 | 36,500 | 36,500 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2018 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2018 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2018 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2018 | 31,500 | 31,500 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2018 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2018 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Other type of transaction at price $ 2.15 per share. | 31 Aug 2017 | 8,240 | 312,643 (2%) | 0% | 2.2 | 17,716 | Common Stock |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Other type of transaction at price $ 2.15 per share. | 31 Aug 2017 | 1,115 | 225,723 (1%) | 0% | 2.1 | 2,397 | Common Stock |
| Marilyn R. Carlson | Chief Medical Officer | Other type of transaction at price $ 2.15 per share. | 31 Aug 2017 | 4,023 | 28,537 (0%) | 0% | 2.1 | 8,649 | Common Stock |
| Cam L. Garner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2017 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Scott L. Glenn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2017 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Ann D. Rhoads | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2017 | 36,500 | 36,500 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2017 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2017 | 31,500 | 31,500 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2017 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Other type of transaction at price $ 1.60 per share. | 28 Feb 2017 | 12,000 | 304,403 (2%) | 0% | 1.6 | 19,200 | Common Stock |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Other type of transaction at price $ 1.60 per share. | 28 Feb 2017 | 12,000 | 224,608 (1%) | 0% | 1.6 | 19,200 | Common Stock |
| Marilyn R. Carlson | Chief Medical Officer | Other type of transaction at price $ 1.60 per share. | 28 Feb 2017 | 7,875 | 24,514 (0%) | 0% | 1.6 | 12,600 | Common Stock |
| Kenneth J. Widder | None | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 22 Feb 2017 | 418,605 | 1,472,867 (9%) | 2% | 2.9 | 1,213,955 | Common Stock |
| Kenneth J. Widder | None | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 22 Feb 2017 | 20,930 | 73,641 (0%) | 0% | 2.9 | 60,697 | Common Stock |
| Kenneth J. Widder | None | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 22 Feb 2017 | 10,465 | 36,821 (0%) | 0% | 2.9 | 30,349 | Common Stock |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2017 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2017 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2017 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cam L. Garner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2016 | 20,500 | 20,500 | - | - | Stock Option (Right to Buy) | |
| Ann D. Rhoads | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2016 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Scott L. Glenn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2016 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2016 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2016 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2016 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Apr 2016 | 61 | 16,208 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Apr 2016 | 21 | 16,269 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Apr 2016 | 3,603 | 950,403 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Apr 2016 | 1,492 | 954,006 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Apr 2016 | 632 | 16,366 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Apr 2016 | 76 | 16,290 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Apr 2016 | 37,054 | 959,922 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Apr 2016 | 4,424 | 955,498 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Apr 2016 | 4,348 | 996,976 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Apr 2016 | 75 | 16,998 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Apr 2016 | 251 | 17,073 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Apr 2016 | 8,669 | 1,043,659 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Apr 2016 | 475 | 17,324 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Apr 2016 | 14,554 | 1,001,324 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Apr 2016 | 148 | 17,799 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Apr 2016 | 27,781 | 1,015,878 | - | - | Common Stock | |
| David A. Gonyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Mar 2016 | 4,669 | 292,403 | - | - | Common Stock | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Other type of transaction at price $ 0.00 per share. | 01 Mar 2016 | 10,937 | 212,608 | - | - | Common Stock | |
| Marilyn R. Carlson | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 01 Mar 2016 | 7,331 | 16,639 | - | - | Common Stock | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2016 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2016 | 94,250 | 0 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2016 | 70,687 | 70,687 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2016 | 80,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2016 | 70,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2016 | 70,687 | 70,687 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2016 | 94,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2016 | 52,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2016 | 33,750 | 33,750 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2016 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2016 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2016 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 31 Aug 2015 | 4,023 | 287,734 | - | - | Common Stock | |
| Marilyn R. Carlson | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 31 Aug 2015 | 1,994 | 9,308 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Aug 2015 | 202 | 17,947 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Aug 2015 | 11,836 | 1,052,328 | - | - | Common Stock | |
| Cam L. Garner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Ann D. Rhoads | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Scott L. Glenn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2015 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Apr 2015 | 554 | 18,149 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Apr 2015 | 9,832 | 1,104,495 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Apr 2015 | 135 | 18,703 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Apr 2015 | 7,920 | 1,096,575 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Apr 2015 | 168 | 18,838 | - | - | Common Stock | |
| Jesse I. Treu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Apr 2015 | 32,411 | 1,064,164 | - | - | Common Stock | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2015 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2015 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 27 Feb 2015 | 2,711 | 283,711 | - | - | Common Stock | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Other type of transaction at price $ 0.00 per share. | 27 Feb 2015 | 6,671 | 201,671 | - | - | Common Stock | |
| Marilyn R. Carlson | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 27 Feb 2015 | 6,058 | 7,314 | - | - | Common Stock | |
| David A. Gonyer | Director, President and CEO | 31 Dec 2014 | 164,000 | 281,000 | - | - | Common Stock | ||
| David A. Gonyer | Director, President and CEO | 31 Dec 2014 | 164,000 | 281,000 | - | - | Common Stock | ||
| Todd C. Brady | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Sep 2014 | 4,000 | 4,000 | - | - | Common Stock | |
| Malcolm R. Hill | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2014 | 5,250 | 0 | - | - | Stock Option (right to buy) | |
| Malcolm R. Hill | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2014 | 5,250 | 19,250 | - | - | Common Stock | |
| Marilyn R. Carlson | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 29 Aug 2014 | 1,256 | 1,256 | - | - | Common Stock | |
| Cam L. Garner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Ann D. Rhoads | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Scott L. Glenn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2014 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2013 | 94,250 | 94,250 | - | - | Stock Option (Right to Buy) | |
| Matthew J. D'Onofrio | Exec VP, Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2013 | 94,250 | 94,250 | - | - | Stock Option (Right to Buy) | |
| Marilyn R. Carlson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2013 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| James C. Blair | Ten Percent Owner | 30 Sep 2013 | 19,006 | 0 | - | - | Series A Preferred Stock | ||
| James C. Blair | Ten Percent Owner | 30 Sep 2013 | 19,006 | 19,006 | - | - | Common Stock | ||
| James C. Blair | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 0 | - | - | Series A Preferred Stock | ||
| James C. Blair | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 1,114,327 | - | - | Common Stock | ||
| Jesse I. Treu | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 0 | - | - | Series A Preferred Stock | ||
| Jesse I. Treu | Ten Percent Owner | 30 Sep 2013 | 19,006 | 19,006 | - | - | Common Stock | ||
| Jesse I. Treu | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 1,114,327 | - | - | Common Stock | ||
| Jesse I. Treu | Ten Percent Owner | 30 Sep 2013 | 19,006 | 0 | - | - | Series A Preferred Stock | ||
| Cam L. Garner | None | 30 Sep 2013 | 78,027 | 0 | - | - | Series A Preferred Stock | ||
| Cam L. Garner | None | 30 Sep 2013 | 15,605 | 335,605 | - | - | Common Stock | ||
| Brian H. Dovey | Ten Percent Owner | 30 Sep 2013 | 19,006 | 19,006 | - | - | Common Stock | ||
| Brian H. Dovey | Ten Percent Owner | 30 Sep 2013 | 19,006 | 0 | - | - | Series A Preferred Stock | ||
| Brian H. Dovey | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 1,114,327 | - | - | Common Stock | ||
| Brian H. Dovey | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 0 | - | - | Series A Preferred Stock | ||
| Nicole Vitullo | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 0 | - | - | Series A Preferred Stock | ||
| Nicole Vitullo | Ten Percent Owner | 30 Sep 2013 | 19,006 | 19,006 | - | - | Common Stock | ||
| Nicole Vitullo | Ten Percent Owner | 30 Sep 2013 | 19,006 | 0 | - | - | Series A Preferred Stock | ||
| Nicole Vitullo | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 1,114,327 | - | - | Common Stock | ||
| Scott L. Glenn | None | 30 Sep 2013 | 78,027 | 0 | - | - | Series A Preferred Stock | ||
| Scott L. Glenn | None | 30 Sep 2013 | 15,605 | 15,605 | - | - | Common Stock | ||
| Brian K. Halak | Ten Percent Owner | 30 Sep 2013 | 19,006 | 19,006 | - | - | Common Stock | ||
| Brian K. Halak | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 1,114,327 | - | - | Common Stock | ||
| Brian K. Halak | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 0 | - | - | Series A Preferred Stock | ||
| Brian K. Halak | Ten Percent Owner | 30 Sep 2013 | 19,006 | 0 | - | - | Series A Preferred Stock | ||
| Schoemaker K Kathleen | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 1,114,327 | - | - | Common Stock | ||
| Schoemaker K Kathleen | Ten Percent Owner | 30 Sep 2013 | 19,006 | 0 | - | - | Series A Preferred Stock | ||
| Schoemaker K Kathleen | Ten Percent Owner | 30 Sep 2013 | 19,006 | 19,006 | - | - | Common Stock | ||
| Schoemaker K Kathleen | Ten Percent Owner | 30 Sep 2013 | 1,114,327 | 0 | - | - | Series A Preferred Stock | ||
| Kenneth J. Widder | Director, Ten Percent Owner | 30 Sep 2013 | 5,271,317 | 0 | - | - | Series A Preferred Stock | ||
| Kenneth J. Widder | Director, Ten Percent Owner | 30 Sep 2013 | 1,054,262 | 1,054,262 | - | - | Common Stock | ||
| Kenneth J. Widder | Director, Ten Percent Owner | 30 Sep 2013 | 263,556 | 0 | - | - | Series A Preferred Stock | ||
| Kenneth J. Widder | Director, Ten Percent Owner | 30 Sep 2013 | 131,784 | 0 | - | - | Series A Preferred Stock | ||
| Kenneth J. Widder | Director, Ten Percent Owner | 30 Sep 2013 | 52,711 | 52,711 | - | - | Common Stock | ||
| Kenneth J. Widder | Director, Ten Percent Owner | 30 Sep 2013 | 26,356 | 26,356 | - | - | Common Stock | ||
| Cam L. Garner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2013 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Ann D. Rhoads | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2013 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Scott L. Glenn | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2013 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Todd C. Brady | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2013 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Malcolm R. Hill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2013 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Kenneth J. Widder | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2013 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) |